SE468831B - Monoklonala antikroppar som aer korsreaktiva och korsprotektiva mot p aeruginosa-sero-typer - Google Patents

Monoklonala antikroppar som aer korsreaktiva och korsprotektiva mot p aeruginosa-sero-typer

Info

Publication number
SE468831B
SE468831B SE8605295A SE8605295A SE468831B SE 468831 B SE468831 B SE 468831B SE 8605295 A SE8605295 A SE 8605295A SE 8605295 A SE8605295 A SE 8605295A SE 468831 B SE468831 B SE 468831B
Authority
SE
Sweden
Prior art keywords
antibody
iats
serotypes
fisher
iats serotypes
Prior art date
Application number
SE8605295A
Other languages
English (en)
Swedish (sv)
Other versions
SE8605295D0 (sv
SE8605295L (sv
Inventor
A W Siadak
M J Rosok
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of SE8605295D0 publication Critical patent/SE8605295D0/xx
Publication of SE8605295L publication Critical patent/SE8605295L/xx
Publication of SE468831B publication Critical patent/SE468831B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE8605295A 1985-12-10 1986-12-10 Monoklonala antikroppar som aer korsreaktiva och korsprotektiva mot p aeruginosa-sero-typer SE468831B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80739485A 1985-12-10 1985-12-10
US93117986A 1986-11-24 1986-11-24

Publications (3)

Publication Number Publication Date
SE8605295D0 SE8605295D0 (sv) 1986-12-10
SE8605295L SE8605295L (sv) 1987-06-11
SE468831B true SE468831B (sv) 1993-03-29

Family

ID=27123006

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8605295A SE468831B (sv) 1985-12-10 1986-12-10 Monoklonala antikroppar som aer korsreaktiva och korsprotektiva mot p aeruginosa-sero-typer

Country Status (21)

Country Link
US (4) US5378812A (fr)
JP (1) JPH07116237B2 (fr)
KR (1) KR910008361B1 (fr)
CN (1) CN86108380A (fr)
AT (1) AT400441B (fr)
BE (1) BE905890A (fr)
CH (1) CH677362A5 (fr)
DE (1) DE3642095C2 (fr)
DK (1) DK594586A (fr)
FI (1) FI86377C (fr)
FR (1) FR2593826B1 (fr)
GB (1) GB2185266B (fr)
HU (1) HUT41836A (fr)
IE (1) IE59741B1 (fr)
IT (1) IT1199735B (fr)
LU (1) LU86711A1 (fr)
NL (1) NL8603132A (fr)
NO (1) NO178718C (fr)
NZ (1) NZ218499A (fr)
PT (1) PT83894B (fr)
SE (1) SE468831B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81370A (en) * 1986-02-07 1991-06-30 Genetic Systems Corp Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
DK172840B1 (da) * 1986-07-03 1999-08-09 Genetic Systems Corp Monoklonale antistoffer mod Pseudomonas aeruginosa flagella, farmaceutiske præparater indeholdende sådanne antistoffer og c
EP0256713A3 (fr) * 1986-08-06 1989-02-15 Merck & Co. Inc. Anticorps humains thérapeutiques anti-pseudomonas aeruginosa
KR910004868B1 (ko) * 1986-12-15 1991-07-15 미츠이 도아츠 가가쿠 가부시기가이샤 인체 단일 클론항체 및 그것을 활성성분으로 함유하는 감염증의 예방 및 치료용 약학적 제제
US5521085A (en) * 1986-12-15 1996-05-28 Mitsui Toatsu Chemicals, Inc. Transformed cell lines producing human monoclonal antibodies specific for Pseudomonas aeruginosa serotypes
JPH01197500A (ja) * 1988-01-29 1989-08-09 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
GB2218703B (en) * 1988-05-10 1992-10-28 Sumitomo Chemical Co Human monoclonal antibody to p.aeruginosa: its production and use
CA1341375C (fr) * 1988-10-12 2002-07-09 Baxter International Inc. Compositions pour le traitement et la prevention d'infections dues a des bacteries gram negatif, ainsi que leurs methodes d'utilisation
EP0382031A3 (fr) * 1989-02-10 1991-06-26 Miles Inc. Anticorps monoclonaux dans une préparation de globuline d'immunsérum
US4994269A (en) * 1989-03-17 1991-02-19 Miles Inc. Topical use of antibodies for prevention or treatment of pseudomonas infections
CA2028815A1 (fr) * 1989-03-20 1990-09-21 Yuko Mizuno Anticorps monoclonaux humains reagissant a pseudomonas aeruginosa, cellules capables de produire lesdits anticorps, methodes de production et preparations pharmaceutique
JPH02283294A (ja) * 1989-04-24 1990-11-20 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
WO1990013660A2 (fr) * 1989-05-09 1990-11-15 Cetus Corporation Anticorps monoclonaux humains de determinants sero-specifiques de bacteries gram-negatives
US5858728A (en) * 1991-03-13 1999-01-12 Common Services Agency Monoclonal antibody against LPS core
US20030096315A1 (en) 2000-05-03 2003-05-22 Sanders Mitchell C. Device for detecting bacterial contamination and method of use
AU2003212897B2 (en) * 2002-01-31 2007-08-02 Expressive Constructs, Inc. Method for detecting microorganisms
WO2003102142A2 (fr) * 2002-05-29 2003-12-11 Henry M. Jackson Foundation For The Advancement Of Military Medicine Inc. Methodes d'identification de biomarqueurs genomiques et proteomiques pour la mucoviscidose, jeux ordonnes d'echantillons comprenant ces biomarqueurs et methodes d'utilisation de ces jeux ordonnes d'echantillons
WO2004047778A1 (fr) * 2002-11-26 2004-06-10 Uc Tech Materiaux et procedes pour la prevention et le traitement de troubles epitheliaux a mediation microbienne
EP1587948A2 (fr) * 2003-01-31 2005-10-26 Ethicon, Inc. Methode de detection d'escherichia coli
ATE382862T1 (de) * 2003-11-03 2008-01-15 Ethicon Inc Verfahren, peptide und biosensoren mit eignung zum nachweis eines breiten spektrums von bakterien
EP1690875A1 (fr) * 2005-02-14 2006-08-16 Kenta Biotech AG Anticorps monoclonal humain specifique pour lipoplysaccharides (LPS) de la Pseudomonas aeruginosa serotype IATS O11
EP2012669B1 (fr) * 2006-05-01 2013-03-13 Bioness Neuromodulation Ltd Systemes de stimulation electrique fonctionnelle ameliores
US20100272736A1 (en) * 2009-02-04 2010-10-28 Kalobios Pharmaceuticals, Inc. Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
EP2536836A4 (fr) * 2010-02-18 2013-08-28 Meiji Seika Pharma Co Ltd Anticorps dirigé contre le lipopolysaccharide de sérotype a de pseudomonas aeruginosa
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH652145A5 (de) * 1982-01-22 1985-10-31 Sandoz Ag Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
US4464465A (en) * 1982-04-05 1984-08-07 Genetic Systems Corporation Cell-driven viral transfer in eukaryotes
JPS59137497A (ja) * 1983-01-20 1984-08-07 ザ・リ−ジエンツ・オブ・ザ・ユニバ−シテイ・オブ・カリフオルニア 抗原特異的免疫グロブリン生産性ヒト／ヒトハイブリド−マ及びその生産する抗体
JPS58216125A (ja) * 1982-06-09 1983-12-15 Asahi Chem Ind Co Ltd ヒト抗体の産生方法
JPS5929622A (ja) * 1982-08-10 1984-02-16 Meiji Seika Kaisha Ltd モノクロ−ナル抗体、その製造法およびその用途
AU585200B2 (en) * 1983-05-06 1989-06-15 Velos Group Monoclonal antibodies reactive with endotoxin core
US4587121A (en) * 1983-06-14 1986-05-06 Miles Laboratories, Inc. High titer Pseudomonas immune serum globulin
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
EP0168422A1 (fr) * 1983-12-12 1986-01-22 Meru, Inc. Procede et substances permettant l'identification de micro-organismes produisant du lipopolysaccharide
US4683196A (en) * 1983-12-12 1987-07-28 Meru, Inc. Method and materials for the identification of lipopolysaccharide producing microorganisms
JPS60248625A (ja) * 1984-05-25 1985-12-09 Mitsui Toatsu Chem Inc 抗緑膿菌モノクロ−ナル抗体、その製法ならびに用途
JP2565303B2 (ja) * 1984-05-25 1996-12-18 三井東圧化学株式会社 緑膿菌感染症の予防治療剤
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
DE3426903A1 (de) * 1984-07-20 1986-01-23 Biotest Pharma GmbH, 6000 Frankfurt Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten
EP0233289B1 (fr) * 1984-12-26 1993-03-10 Teijin Limited Hybriodomes produisant anti-pseudomonas aeruginosa human monoclonal antibody
US4677070A (en) * 1985-04-26 1987-06-30 Cetus Corporation Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use
JPS6229175A (ja) * 1985-07-29 1987-02-07 Nippon Telegr & Teleph Corp <Ntt> 電界効果型トランジスタの製造方法
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
EP0211352B1 (fr) * 1985-08-01 1994-03-16 Miles Inc. Anticorps protecteurs contre des déterminants sérotypiques d'antigènes flagellaires
US4777136A (en) * 1985-09-27 1988-10-11 The Regents Of The University Of California Monoclonal antibody reactive with Pseudomonas Aeruginosa
US4970070A (en) * 1986-02-07 1990-11-13 Genetic Systems Corporation Protective monoclonal antibody compositions for infections due to group B streptococcus
DK172840B1 (da) * 1986-07-03 1999-08-09 Genetic Systems Corp Monoklonale antistoffer mod Pseudomonas aeruginosa flagella, farmaceutiske præparater indeholdende sådanne antistoffer og c
EP0256713A3 (fr) * 1986-08-06 1989-02-15 Merck & Co. Inc. Anticorps humains thérapeutiques anti-pseudomonas aeruginosa

Also Published As

Publication number Publication date
JPH07116237B2 (ja) 1995-12-13
FI86377B (fi) 1992-05-15
NO864971L (no) 1987-06-11
SE8605295D0 (sv) 1986-12-10
IE59741B1 (en) 1994-03-23
IE863230L (en) 1987-06-10
PT83894A (en) 1987-01-01
DE3642095A1 (de) 1987-07-02
US5662905A (en) 1997-09-02
FR2593826B1 (fr) 1990-11-16
NO178718B (no) 1996-02-12
GB8629540D0 (en) 1987-01-21
US5628996A (en) 1997-05-13
IT1199735B (it) 1988-12-30
HUT41836A (en) 1987-05-28
FI865027A (fi) 1987-06-11
SE8605295L (sv) 1987-06-11
CN86108380A (zh) 1987-10-28
DK594586A (da) 1987-06-11
KR870005648A (ko) 1987-07-06
DE3642095C2 (de) 1998-10-01
NL8603132A (nl) 1987-07-01
US5378812A (en) 1995-01-03
CH677362A5 (fr) 1991-05-15
GB2185266B (en) 1990-09-05
LU86711A1 (fr) 1988-07-14
DK594586D0 (da) 1986-12-10
KR910008361B1 (ko) 1991-10-12
NZ218499A (en) 1990-04-26
PT83894B (pt) 1989-07-31
JPS62187417A (ja) 1987-08-15
BE905890A (fr) 1987-06-10
NO178718C (no) 1996-05-22
GB2185266A (en) 1987-07-15
FI865027A0 (fi) 1986-12-10
FR2593826A1 (fr) 1987-08-07
NO864971D0 (no) 1986-12-10
FI86377C (fi) 1992-08-25
US5627067A (en) 1997-05-06
ATA328286A (de) 1995-05-15
IT8622630A0 (it) 1986-12-10
AT400441B (de) 1995-12-27

Similar Documents

Publication Publication Date Title
SE468831B (sv) Monoklonala antikroppar som aer korsreaktiva och korsprotektiva mot p aeruginosa-sero-typer
US4834975A (en) Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
US4689299A (en) Human monoclonal antibodies against bacterial toxins
EP0105804B1 (fr) Anticorps monoclonaux humains contre des toxines bactériennes
JPH0776240B2 (ja) エンドトキシンコア−と反応性のモノクロ−ナル抗体
Morrison-Plummer et al. Biological effects of anti-lipid and anti-protein monoclonal antibodies on Mycoplasma pneumoniae
FI94489B (fi) Menetelmä ristisuojaavien ihmisen monoklonaalisten vasta-aineiden valmistamiseksi ja vasta-ainetta tuottava solulinja
WO1986001805A1 (fr) Anticorps monoclonaux et leur utilisation
WO2008004536A1 (fr) Procédé de détection de toxine
AU615162B2 (en) Monoclonal antibodies to pseudomonas aeruginosa flagella
Lang et al. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization
Chandad et al. Antigenic, structural, and functional relationships between fimbriae and the hemagglutinating adhesin HA-Ag2 of Porphyromonas gingivalis
Verschoor et al. Monoclonal antibody characterization of two field strains of Haemophilus paragallinarum isolated from vaccinated layer hens
Siadak et al. Cell-driven viral transformation
FI102217B (fi) Menetelmä Pseudomonas aeruginosa-serotyyppien toteamiseksi näytteestä in vitro monoklonaalisten vasta-aineiden avulla, menetelmässä käytettä viä monoklonaalisia vasta-aineita sekä menetelmässä käyttökelpoinen te stipakkaus
Kheyar et al. The 64 kDa lipoprotein of Mycoplasma gallisepticum has two distinct epitopes responsible for haemagglutination and growth inhibition
Ghosh et al. Assay dependent specificities of monoclonal antibodies to bacterial antigens.
EP0326148A1 (fr) Anticorps monoclonal humain spécifique à Pseudomonas aeruginosa et lignes de cellules hybrides
Dénes et al. Recognition of multiple Mycoplasma bovis antigens by monoclonal antibodies
JP2587770B2 (ja) 形質転換細胞
Viral ANTHONY W. SIADAK AND MARK E. LOSTROM
JPH0355106B2 (fr)

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8605295-8

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8605295-8

Format of ref document f/p: F